Statement 9 Sep 2019

New report provides a policy framework to support countries in implementing an effective life-course approach to immunization

GENEVA, 12 September 2019 – The report “Implementing a Life-Course Approach to Immunization” provides a policy framework for countries to implement effective policies in order to maximize individual and population-wide health and economic benefits of a life-course approach to immunization. A life-course approach requires that immunization schedules and access to vaccination respond to an individual’s stage...

Read more
Statement 9 Sep 2019

Industry and Stakeholders reaffirm their commitment to ensuring ethics and integrity across health systems

GENEVA, 10 SEPTEMBER 2019: IFPMA is proud to be a key partner of the Business Ethics for APEC SMEs initiative, the largest public-private partnership of its kind in the world with participation from more than 1,250 organizations across all 21 APEC member economies all working towards achieving ethics and integrity in the service of patients...

Read more
Expert insight 2 Sep 2019

Five questions to …. Paola Barbarino

Paola Barbarino, Chief Executive Officer at Alzheimer’s Disease International (ADI), talks to IFPMA about changing attitudes and perceptions surrounding dementia and Alzheimer’s.  Is mental health getting enough attention in the UHC discussions and what are your hopes for the upcoming UN High Level Meeting on UHC? Following on from the High-Level Meeting on Non-Communicable Diseases...

Read more
Statement 30 Aug 2019

IFPMA calls for regulatory convergence to speed up development of much needed vaccines

GENEVA, 2 September 2019 – Today, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) launched a new report titled ‘Complex Journey of a Vaccine: The Steps behind Developing a New Vaccine’. The report highlights three major factors that contribute to the lengthy development process of a novel vaccine, and highlights the challenges that manufacturers...

Read more
Statement 22 Aug 2019

IFPMA Statement on WHO Afro 69 agenda item 12 Framework for provision of essential health services through strengthened district/local health systems to support UHC in the context of the SDGs

Delivered by Cyntia Genolet, Head System strengthening and Africa Policy, IFPMA Thank you for the opportunity to contribute to this important discussion today. IFPMA represents leading research-based pharmaceutical companies as well as national and regional industry associations across the world, including three associations in Africa. IFPMA stands together with the global health community to support...

Read more
Expert insight 15 Aug 2019

The search for a dementia cure rests on helping innovators

This article was originally published in the Financial Times on August 6, 2019.  The search for a dementia cure rests on helping innovators Governments must steer private funding towards difficult diseases Innovation can change the maths of Alzheimer’s disease. But to do that, governments need to change the maths for innovators. The estimated annual global...

Read more
Expert insight 5 Aug 2019

Five questions to …. David Stewart

David Stewart, Associate Director, Nursing and Health Policy at the International Council of Nurses (ICN) talks to IFPMA about the importance of nurses in achieving universal health coverage. Earlier this year, Dr Tedros endorsed 2020 as the Year of Nurses and Midwives. What are your hopes for 2020? We have been working with Dr Tedros...

Read more
Report 29 Jul 2019

The Complex Journey of a Vaccine – The Steps Behind Developing a New Vaccine

Read more
External study 24 Jul 2019

The Global Innovation Index 2019 Report

The Global Innovation Index (GII) ranks the innovation performance of 129 countries and economies around the world, based on 80+ indicators. Co-published by WIPO, Cornell University and INSEAD, the report provides an annual ranking of the innovation capabilities and performance of economies around the world. This year’s report features a chapter titled “Reaching New Frontiers...

Read more
Expert insight 18 Jul 2019

Overcoming Access Barriers to Antibiotics

This blog was originally published on CDDEP website on 15 July 2019. Somewhat perversely, antibiotic overuse exists side-by-side with lack of access to such medicines in today’s world. While we are aware of the consequences of drug-resistant bacterial infections, it is less well known that there are millions of people in low- and middle-income countries...

Read more
Expert insight 10 Jul 2019

Five questions to …. Kawaldip Sehmi

Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organizations (IAPO) talks to IFPMA about why the Essential Medicines List is important for patients. What does the addition of new medicines on the 2019 EML update mean for patients? The inclusion of any medicine, including innovative and specialty medicines, on the World Health Organization’s Essential...

Read more
Expert insight 27 Jun 2019

Flu can cause up to 650,000 deaths a year globally

This blog was originally published on Health Awareness Value of Vaccines 2019 campaign on 27 June 2019. Influenza is a highly infectious disease that usually strikes during the winter season. Globally, it causes an estimated one billion cases of influenza, resulting in 290,000 to 650,000 deaths per year. A person can get the virus simply...

Read more